Endeavor

New FDA-Approved Therapy Offers Hope for Patients With Advanced Melanoma

A first-of-its-kind oncolytic viral immunotherapy combination offers a new option for patients

What Are Bispecifics and How Do They Help Patients With Cancer?

A new class of immunotherapy is giving doctors another way to guide the immune system toward hard to treat cancers

Study Tests Immune-Boosting Approach for Advanced Lung Cancer

Researchers are studying a new drug combination for patients with advanced non-small cell lung cancer who have limited treatment options after immunotherapy

Could Novel Breast Cancer Immunotherapy Reduce Need for Chemotherapy?

Study shows dendritic cell therapy enhances immune response in HER2-positive breast cancer

How One Moffitt Team Is Using AI To Help Decode Cancer Care

ECHO is designed to help researchers connect complex cancer data faster while keeping human expertise at the center of every decision

Inside the Breakthroughs That Changed Melanoma Care

Moffitt researchers helped drive decades of FDA approvals that transformed patient outcomes

Could Immunotherapy Help Patients Avoid Surgery for Precancerous Oral Lesions?

Early trial findings show intralesional nivolumab shrinks lesions and may help patients avoid resection

Can AI Predict Who Responds to Immunotherapy?

A deep learning platform uses routine pathology slides to better predict treatment response in lung cancer patients

Turning the Immune System Back On: A New Approach to Treating Breast Cancer

Blocking a specific enzyme may unlock the immune system’s potential to attack tumors